Soluble and membrane isoforms of Fas/CD95 in fresh adult T‐cell leukemia (ATL) cells and ATL‐cell lines

Fas, also designated as Apo‐1 and CD95, is a cell membrane receptor (mFas) involved in apoptotic cell death. A soluble form (sFas) lacking the transmembrane domain due to alternative splicing has been isolated. Abnormal expression of sFas and mFas is likely to be involved in lymphoproliferative disorders and auto‐immune diseases. Adult T‐cell leukemia (ATL) caused by human T‐cell‐leukemia virus type‐1 (HTLV‐1) is well known to be a T‐cell neoplasm with strong mFas expression, suggesting a role of Fas in the pathology of the disease. We examined protein and mRNA expression of the 2 isoforms of Fas in fresh ATL cells and ATL cell lines. In general, mFas was strongly expressed in ATL cells, and sFas levels in sera were high, especially in malignant ATL. However, expression of the isoforms in some cases of ATL varied; there was no mFas expression on the cell surface and sFas levels were high in serum. In contrast, all ATL cell lines examined showed strong mFas expression and scarce production of sFas in the supernatant, corresponding to strong expression of full‐length Fas mRNA and weak to negative expression of alternatively spliced mRNA lacking the transmembrane domain. Our findings indicate that the mode of expression of Fas isoforms in ATL cells is not always homogenous and that Fas may play a role in the malignant behavior and oncogenesis of ATL. Int. J. Cancer 72:128–132, 1997. © 1997 Wiley‐Liss Inc.

[1]  F. Rieux-Laucat,et al.  Clinical, immunological, and pathological consequences of Fas-deficient conditions , 1996, The Lancet.

[2]  M. Tomonaga,et al.  Features of the cytokines secreted by adult T cell leukemia (ATL) cells. , 1996, Leukemia & lymphoma.

[3]  D. Golde,et al.  Soluble cytokine receptors. , 1996, Blood.

[4]  P. Kleihues,et al.  Astrocytomas Expression of Fas/apo-1 during the Progression of Updated Version Citing Articles E-mail Alerts Expression of Fas/apo-1 during the Progression of Astrocytomas , 2022 .

[5]  F. Rieux-Laucat,et al.  Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. , 1995, Science.

[6]  P. Krammer,et al.  Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias. , 1995, Blood.

[7]  M. Tomonaga,et al.  Established IL‐2‐dependent double‐negative (CD4‐ CD8‐) TCRαβ/CD3+ ATL cells: induction of CD4 expression , 1994 .

[8]  M. Tomonaga,et al.  Significance of soluble interleukin‐2 receptor levels for evaluation of the progression of adult T‐cell leukemia , 1994, Cancer.

[9]  H. Winn,et al.  Immunologically nonspecific mechanisms of tissue destruction in the rejection of skin grafts , 1994, The Journal of experimental medicine.

[10]  I. Behrmann,et al.  Regulation of apoptosis in the immune system. , 1994, Current opinion in immunology.

[11]  Matthew J. Brauer,et al.  Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. , 1994, Science.

[12]  P. Krammer,et al.  Differential expression of APO‐1 on human thymocytes: Implications for negative selection? , 1994, European journal of immunology.

[13]  Takashi Suda,et al.  Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family , 1993, Cell.

[14]  M. Seldin,et al.  Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci , 1992, The Journal of experimental medicine.

[15]  M. Pawlita,et al.  Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. , 1992, The Journal of biological chemistry.

[16]  S. Kamihira,et al.  Phenotypic diversity and prognosis of adult T-cell leukemia. , 1992, Leukemia research.

[17]  N. Copeland,et al.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis , 1992, Nature.

[18]  M. Shimoyama,et al.  Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma , 1991, British journal of haematology.

[19]  Atsushi Hase,et al.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis , 1991, Cell.

[20]  S. Yonehara,et al.  A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor , 1989, The Journal of experimental medicine.

[21]  P. Carayon,et al.  Cytofluorometric quantification of cell-surface antigens by indirect immunofluorescence using monoclonal antibodies. , 1985, Journal of immunological methods.

[22]  P. Black,et al.  Shedding from the cell surface of normal and cancer cells. , 1980, Advances in cancer research.